Connect with us
Reig Jofre invests €5.8 million in Leanbio for vertical integration in biotechnology. They increase their stake to 24%, committing to expanding further. The collaboration aims to...
Johnson & Johnson announces the acquisition of Shockwave Medical for $13.1 billion, expanding its presence in cardiovascular intervention. Subject to shareholder and regulatory approval, the deal...
Grifols leads the IBEX 35's mid-morning gains, rising 3.42% to 9.02 euros, marking its fourth consecutive positive day. Despite falling over 40% for the year, the...
ACS Biotech has developed a unique gel in the world capable of repairing cartilage damage occurring following traumatic shock or a degenerative disease such as osteoarthritis....
Rovi has gained FDA approval for its drug Risvan to treat schizophrenia in adults. The approval led to a nearly 3% surge in Rovi's stock. Risvan,...
The Spanish pharma sector faced a downturn in the stock market in Q1 of 2024, with a collective market capitalization drop of 15.8% for six listed...
The European Medicines Agency (EMA) is close to authorizing UCB's new treatment, Bimzelx, for hidradenitis suppurativa. The positive assessment from the Chmp suggests it could be...
PharmaMar started February with falls of almost 3% at the opening of the market. The reason was that Sylentis had failed in its primary objective of...
Atrys Health reports 2023 losses of 45 million euros, nearly doubling from the previous year, despite a 27.3% increase in revenue to 202 million euros and...
Faes Farma forecasts a double-digit growth in Latin America and plans to expand its medical visit, animal nutrition, and health businesses. The Spanish pharmaceutical company aims...
 |
|
 |  |
 |
|